Try our beta test site
1 study found for:    LOR-253 | Hematologic Malignancies
Show Display Options
Rank Status Study
1 Suspended A Study of APTO-253 HCl in Patients With Relapsed or Refractory Hematologic Malignancies
Conditions: Relapsed Hematologic Malignancies;   Refractory Hematologic Malignancies
Intervention: Drug: APTO-253 HCl

Study has passed its completion date and status has not been verified in more than two years.